Преглед Article тема: "P-glycoprotein"
Приказ резултата 1-11 од 11
-
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors
(Lausanne : Frontiers Media, 2022) -
C20-nor-Abietane and Three Abietane Diterpenoids from Plectranthus mutabilis Leaves as P-Glycoprotein Modulators.
(ACS Medicinal Chemistry Letters, 2022) -
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
(European Journal of Pharmaceutical Sciences, 2017) -
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment.
(Current Medicinal Chemistry, 2019) -
New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
(Current Pharmaceutical Design, 2015) -
Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
(Current Pharmaceutical Design, 2018) -
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
(European Journal of Pharmaceutical Sciences, 2019) -
Two new jatrophane diterpenes from the roots of Euphorbia nicaeensis
(Belgrade : Serbian Chemical Society, 2021)